Registry for patients undergoing rotational atherectomy for coronary artery disease
A Prospective Follow-up Assessment in Bad Segeberg With Patients Undergoing a Rotational Atherectomy in Coronary Lesion/s
This study is collecting information from patients who have had rotational atherectomy for heart artery problems to see how well the treatment works and what effects it has over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Segeberger Kliniken GmbH Academic / other |
| Locations | 1 site (Bad Segeberg) |
| Trial ID | NCT04011527 on ClinicalTrials.gov |
What this trial studies
This registry collects data from patients treated with rotational atherectomy for coronary artery lesions at the Heart Center in Bad Segeberg, Germany. It involves a prospective follow-up assessment to monitor patient outcomes and gather long-term data on the effectiveness of the procedure. The study aims to provide insights into the clinical benefits and risks associated with this treatment approach.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients undergoing rotational atherectomy for calcified coronary artery lesions.
Not a fit: Patients not undergoing rotational atherectomy or those with non-calcified lesions may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of rotational atherectomy outcomes, potentially improving treatment strategies for coronary artery disease.
How similar studies have performed: While similar observational registries have been conducted, this specific approach to rotational atherectomy is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients undergoing a rotational atherectomy of coronary lesion/s Exclusion Criteria: * None
Where this trial is running
Bad Segeberg
- Herzzentrum Segeberger Kliniken GmbH — Bad Segeberg, Germany (Recruiting)
Study contacts
- Study coordinator: Abdelhakim Allali, MD
- Email: allali.abdelhakim@gmail.com
- Phone: +4945512802
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.